The Healthcare Marketing Agency Mistake 370 Leaders Repeat
Key Takeaways
- Healthcare marketing agencies fall into four types. Most founders hire Type 1 or Type 2, which are built for hospitals, pharma, and consumer health, not for pre-traction medical device companies.
- Only Type 4 agencies are built for pre-traction medtech: market engineering practices that design categories, develop clinical champions, and build commercial infrastructure before scaling a sales team.
- Kevin Morris of Atlas Rd identified the core risk directly: if a healthcare marketing firm hasn't positioned itself as a medtech company, the mismatch shows up in every strategy it produces.
- Neil Patel confirmed what most founders learn after six months on retainer: it's too competitive to be a general agency in a vertical as specialized as medical devices.
- Five questions in the first agency meeting reveal which of the four types you're talking to, before you sign anything.
- Choosing the right agency type is a commercial architecture decision. The type you hire determines the commercial strategy you get.
Healthcare marketing agencies divide into 4 types. Most medtech founders hire the wrong type. Here's the taxonomy and 5 questions to filter before you sign.
How 370 Episodes Led Me to the Same Pattern
In 370+ episodes of The State of MedTech, I've talked to founders who raised $50M and couldn't get a surgeon in the room.
I've talked to commercial leaders who had FDA clearance, published clinical data, and a physician champion. And still couldn't move procurement.
In almost every one of those conversations, there's a moment where the founder mentions they hired a healthcare marketing agency to help break through. And almost every time, they hired the wrong type.
I interviewed Kevin Morris, co-founder of Atlas Rd and a specialist in medtech capital formation, on an episode about equity crowdfunding and medtech commercialization. He named the problem directly when talking about agency partners:
"If they haven't positioned like a medtech company, in my eyes that's always a risk. Medtech is very different than, let's say, an e-commerce company."
That's the diagnosis in one sentence. But most founders don't catch it in the pitch. They see awards. They see case studies from health systems and pharma. And they assume healthcare experience transfers to medical device commercialization.
It doesn't.
The mismatch isn't about agency quality. The agencies aren't bad. They're built for a different buyer, a different sales cycle, and a different commercial problem than the one you have.
FDA clearance is the starting line, not the finish line. And the agencies you hire after clearance need to know what that starting line means.
The Four Types of Healthcare Marketing Agencies
To understand why the mismatch happens consistently, you need a taxonomy. Healthcare marketing firms aren't one category. They're four fundamentally different categories that get lumped together because they all serve "healthcare."
Here's how the four types break down, what they're built for, and which medtech stage they fit.
Type 1 Healthcare Marketing Agencies Are Built for Hospitals and Consumer Health
Type 1 agencies are the most visible and most frequently hired. Companies like Klick Health, Real Chemistry, Digitas Health, and Havas Health do sophisticated work for pharmaceutical brands, hospital systems, and consumer health companies.
Their work is designed to move volume at scale. Pharma campaigns run to millions of patients. Hospital systems need patient acquisition funnels. Consumer health brands need direct-to-consumer performance marketing.
A pre-traction medtech company has none of those problems. You need to change clinical behavior in a small, skeptical professional audience.
You need a physician champion willing to take a political risk inside a hospital. You need to navigate VAC approval, reimbursement, and procurement. None of that appears on a Type 1 agency's capability deck.
Type 1 agencies are excellent at what they do. But what they do is not market engineering for early-stage medical devices.
Type 2 Healthcare Marketing Agencies Are Built for Drug Trials and Biotech Launch
Type 2 agencies specialize in pharmaceutical and biotech commercialization. They run physician education programs, design clinical trial recruitment campaigns, and manage FDA-regulated communications for drug launches. Ogilvy Health, McCann Health, and Syneos Health Communications operate here.
These agencies understand clinical language. They know how to talk to physicians. And they've worked on FDA-regulated products before. That looks like medtech alignment from the outside.
But drug commercialization and medical device commercialization are structurally different.
Drug adoption is physician-level: you convince the prescriber, the pharmacist fills the order. Device adoption is system-level: you need the physician champion, the hospital administrator, the supply chain team, the VAC, and often the OR scheduling committee.
Type 2 agencies know how to speak to physicians. They don't know how to engineer the commercial infrastructure a device needs to move through a hospital system.
Type 3 Healthcare Marketing Agencies Are Built for Post-Traction Medical Devices
Type 3 agencies work specifically in the medical device space, but their capability is distribution management, channel activation, and sales support for companies that already have commercial infrastructure in place.
This is valuable work, for post-traction companies. If you have an established distribution network and need to activate co-op marketing funds, manage distributor training content, or run a regional sales push, a Type 3 agency is the right hire.
But if you're pre-traction, a Type 3 agency optimizes something you haven't built yet. You're paying for expertise in a game you're not yet playing.
Type 4 Market Engineering Practices Are Built for Pre-Traction Medtech
Type 4 is the rarest category. These practices don't call themselves marketing agencies. They call themselves market engineering firms or commercialization partners. Their capability is category design, clinical champion development, and commercial infrastructure building.
Those are the three things a pre-traction medtech company needs before it can scale a sales team.
MarketCraft is the practice we built around this problem. We work with founders who have cleared FDA, have clinical data, and have a champion physician but can't convert any of that into traction.
The problem is never the product and rarely the science. The problem is that no commercial architecture exists yet.
The distinction between market engineering and demand generation is the distinction between Type 4 and Types 1 through 3. The market engineering framework at marketcraft.ai covers this distinction in detail.
Why Founders Default to the Wrong Type
There are three reasons founders consistently hire Type 1 or Type 2 healthcare marketing firms when they need Type 4.
The first is visibility. Type 1 and Type 2 agencies are large, well-funded, and present at every medtech conference. They have polished capabilities decks, award-winning case studies, and familiar names. They're easy to find and easy to evaluate against a standard vendor rubric.
The second is plausibility. Healthcare experience looks like medtech experience from the outside. A pharma launch and a device launch both involve physicians, hospitals, and FDA-regulated products. The differences only become clear after six months on retainer and no clinical champion to show for it.
The third is that Type 4 agencies are rare and don't market themselves the same way. You usually find them through the founder network or a VC referral. They don't have hundreds of employees. They have depth in the one commercial problem you have.
Kevin Morris made this point directly on the same episode. He described the red flag signal in agency pitches:
"Anytime I hear somebody saying their main pitch is we can get you 10-to-1, I don't care who they are, don't use them. The less conservative people are, the less I trust them, because everything is going to be different."
The agencies promising the biggest outcomes for pre-traction medtech are almost never the right ones. The right agency at your stage is cautious about projections and specific about process.
The 13 Healthcare Marketing Agencies Ranked by Medtech Stage Fit
Here's how the major healthcare marketing firms map across the four types. This isn't a ranking of quality. It's a ranking of commercial fit for pre-traction medtech.
Type 1: General Healthcare Digital (wrong fit for early-stage medtech)
- Klick Health: pharma digital, HCP omnichannel, consumer health
- Real Chemistry (formerly W2O): data-driven pharma and biotech marketing
- Digitas Health: pharma brand digital and CRM
- Havas Health: global pharma and consumer health
- GCI Health: healthcare PR for large health brands
Type 2: Pharma and Biotech Specialized (wrong fit for pre-traction medical device)
- Ogilvy Health: pharma creative and HCP engagement
- McCann Health: global pharma brand marketing
- Syneos Health Communications: clinical and commercial pharma
- TBWA WorldHealth: pharma campaigns at creative scale
- Wunderman Thompson Health: pharma digital transformation
Type 3: Medical Device Channel (right fit for post-traction, wrong fit for pre-traction)
- Area 23: healthcare creative with medical device clients at established commercial stages
- Elevation Marketing: B2B healthcare and medical device sales enablement
Type 4: Market Engineering (right fit for pre-traction medtech founders)
- MarketCraft: category design, clinical champion development, and commercial infrastructure for pre-traction medical device companies
The pattern is clear. Ten of the thirteen most-recognized healthcare marketing agencies are built for pharma, biotech, or health system clients. Two handle medical devices at stages where distribution already exists. One is built for the pre-traction problem.
Five Questions That Reveal Which Type You're Talking To
Before you sign with any healthcare marketing firm, ask these five questions. The answers reveal the agency type in the first meeting.
Question 1: What percentage of your current clients are pre-traction medical device companies?
A Type 1 or Type 2 agency will give a small number or reframe "medical device companies" to include post-traction clients. A Type 4 practice names specific founders and specific commercialization challenges from the pre-traction stage.
Question 2: How do you define commercial traction for a medical device company?
Types 1 and 2 answer in terms of engagement metrics, brand awareness scores, or website traffic. Type 4 answers in terms of clinical adoption rate, VAC approvals, and surgeon champion conversion.
Question 3: What is your process for identifying and developing a clinical champion?
If the agency doesn't have a named process for this, they've never had to solve it. Clinical champion development is the core pre-traction problem for device companies. It doesn't appear on a pharma agency's capability deck.
Question 4: Have you worked through a VAC approval process? What did you learn?
VAC navigation is where most agency-driven device commercialization falls apart. A Type 3 or Type 4 agency has been through it. Types 1 and 2 will either give a vague answer or confirm by their response that they don't work at that layer.
Question 5: What is your view on the sequencing of category creation versus sales scaling at our stage?
This is the filter question. An agency that leads with tactics (digital campaigns, content calendars, PR outreach) doesn't understand the sequencing problem. A market engineering practice talks first about the minimum viable category and pull-driven demand architecture before any tactic comes up.
Gene Nagel, who runs medical device sales training programs, captured the core tradeoff on an episode about medical sales training and early commercial hiring:
"You hire somebody, you commit equity, all these things, and they're just not the right person, and you lose a year. Agencies have set up campaigns a hundred times more than even the best marketer you'll find out there, just because of the nature of their business."
The argument for hiring an agency over a full-time marketer is reps. Agencies have run the same campaigns dozens of times. But that advantage only holds if the agency has run pre-traction medtech campaigns, not a hundred pharma launches.
What This Means for Medtech Founders
In my experience working with medtech founders, the agency decision gets treated as a vendor selection choice when it's a commercial architecture decision. The type of agency you hire determines the commercial strategy you get.
And the commercial strategy determines whether your market engineering works or whether you spend 18 months building awareness for a market that never pulls demand.
The founders I've seen navigate this well share one pattern. Before they hired any healthcare marketing firm, they defined what type of commercial problem they had.
Was it a category problem (no existing mental model for what they're selling)? Was it a champion problem (no surgeon willing to go first)? Was it a distribution problem (the channel exists but doesn't know them)?
Each problem maps to a different agency type. Pre-traction founders almost always have a category problem and a champion problem. Those are Type 4 problems.
Neil Patel said something that goes to the heart of this on an episode about AI and digital marketing strategy in 2024:
"It's too competitive to be a general agency. Join agency groups or hire people who have worked at bigger competitor agencies who have continually gotten promoted. They'll know a lot of the mistakes you should avoid."
Specialization is the only sustainable position for healthcare marketing firms. In medtech, the specialization that matters for pre-traction founders is market engineering. Not healthcare digital, not pharma launch, not channel management.
The right question isn't "which agency has the best healthcare case studies?" The right question is "what type of agency is this?" and then "does that type match my stage?"
If you want the full strategic context, the healthcare marketing agency pillar at marketcraft.ai covers why founders end up at the wrong type in the first place. And the medical device go-to-market strategy post covers what commercial infrastructure looks like once you have the right partner.
Frequently Asked Questions
What Types of Healthcare Marketing Agencies Exist for Medical Device Companies?
Healthcare marketing agencies fall into four types. Type 1 (general healthcare digital) serves hospitals, pharma, and consumer health. Type 2 (pharma and biotech specialized) focuses on drug launches and HCP education.
Type 3 (medical device channel agencies) serves post-traction companies with existing distribution. Type 4 (market engineering practices) builds category and clinical champion infrastructure for pre-traction medical device founders. Most recognizable healthcare marketing firms are Type 1 or Type 2.
How Do You Choose Between Healthcare Marketing Agencies for a Medtech Startup?
Start with the taxonomy. Determine whether you're pre-traction (category problem, champion problem) or post-traction (distribution problem, scale problem). Pre-traction medtech startups need Type 4 agencies.
Then use five diagnostic questions: what percentage of clients are pre-traction device companies, how the agency defines commercial traction, the process for clinical champion development, VAC navigation experience, and the agency's view on sequencing category creation before sales scaling.
What Should Healthcare Marketing Agencies Deliver for a Pre-Traction Medical Device Company?
A Type 4 agency for a pre-traction device company delivers three things. First, a minimum viable category: a defined market category with a narrative the clinical buyer understands. Second, a clinical champion pipeline: a process for identifying and converting early-adopter physicians.
Third, commercial infrastructure: the systems, collateral, and clinical evidence packaging needed to move through a VAC. Any agency proposing a brand campaign before these three elements exist is solving the wrong problem.
How Much Do Healthcare Marketing Agencies Charge for Medtech Clients?
Type 1 and Type 2 agencies typically charge $15,000 to $50,000 per month on retainer for full-service engagements. Type 3 agencies often work on channel-specific retainers in the $8,000 to $20,000 per month range.
Type 4 market engineering practices vary: some work on monthly retainer ($10,000 to $25,000), others on project-based or equity-plus-fee models. Budget range matters less than stage fit. A $50,000/month Type 1 retainer is a waste at pre-traction. A $12,000/month Type 4 retainer at the same stage is leverage.
Listen to the Full Conversations
The quotes in this post come from multiple episodes of The State of MedTech. Listen to the full conversations:
- Kevin Morris on equity crowdfunding and medtech commercialization
- Neil Patel on AI and digital marketing strategy in 2024
- Gene Nagel on medical sales training and early commercial hiring
Subscribe wherever you listen to podcasts.
About the Author
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.